Nautilus Biotechnology (NAUT) Profit After Tax (2020 - 2026)

Nautilus Biotechnology has reported Profit After Tax for 7 years, with the latest figure at -$14.5 million in Q2 2026.

• Quarterly Profit After Tax rose 3.75% year-over-year to -$14.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$56.5 million (up 13.95% YoY) and the FY2025 annual result came in at -$59.0 million, up 16.64% from the prior year.
• Profit After Tax grew to -$14.5 million in Q2 2026 per NAUT's latest filing, from -$14.7 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$11.7 million in Q4 2022 and troughed at -$19.2 million in Q1 2024.
• A 5-year average of -$15.6 million and a median of -$15.5 million in 2022 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 29.77% in 2022, down 87.43% in 2022.
• Over 5 years, Profit After Tax stood at -$11.7 million in 2022, then slumped by 45.36% to -$17.0 million in 2023, then declined by 3.35% to -$17.6 million in 2024, then advanced by 21.67% to -$13.8 million in 2025, then fell by 4.99% to -$14.5 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$14.5 million, -$14.7 million, and -$13.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.